Skip to main content
. 2022 Dec 7;8(2):e002706. doi: 10.1136/rmdopen-2022-002706

Figure 3.

Figure 3

Biologic DMARDs usage for minimal disease activity groups. The percentage of patients per minimal disease activity (MDA) group who uses a biologic DMARD over time.